High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment AC Logan, H Gao, C Wang, B Sahaf, CD Jones, EL Marshall, I Buño, ... Proceedings of the National Academy of Sciences 108 (52), 21194-21199, 2011 | 242 | 2011 |
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm J Menezes, F Acquadro, M Wiseman, G Gómez-López, RN Salgado, ... Leukemia 28 (4), 823-829, 2014 | 191 | 2014 |
Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse … AC Logan, N Vashi, M Faham, V Carlton, K Kong, I Buño, J Zheng, ... Biology of Blood and Marrow Transplantation 20 (9), 1307-1313, 2014 | 150 | 2014 |
Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms F Maas, N Schaap, S Kolen, A Zoetbrood, I Buño, H Dolstra, T de Witte, ... Leukemia 17 (3), 621-629, 2003 | 138 | 2003 |
Diagnostic utility of fluorescence in situ hybridization in mantle‐cell lymphoma ED Remstein, PJ Kurtin, I Buno, RJ Bailey, J Proffitt, WA Wyatt, ... British journal of haematology 110 (4), 856-862, 2000 | 136 | 2000 |
Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion … A Jimenez-Velasco, M Barrios, J Roman-Gomez, G Navarro, I Buno, ... Leukemia 19 (3), 336-343, 2005 | 106 | 2005 |
A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia I Buño, WA Wyatt, AR Zinsmeister, J Dietz-Band, RT Silver, GW Dewald Blood, The Journal of the American Society of Hematology 92 (7), 2315-2321, 1998 | 100 | 1998 |
HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation D Serrano, R Carrión, P Balsalobre, P Miralles, J Berenguer, I Buño, ... Experimental Hematology 33 (4), 487-494, 2005 | 98 | 2005 |
Evaluation of minimal residual disease by real-time quantitative PCR of Wilms’ tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell … M Kwon, C Martínez-Laperche, M Infante, F Carretero, P Balsalobre, ... Biology of Blood and Marrow Transplantation 18 (8), 1235-1242, 2012 | 90 | 2012 |
Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation M Bastos‐Oreiro, A Perez‐Corral, C Martínez‐Laperche, L Bento, ... European Journal of Haematology 93 (3), 239-246, 2014 | 78 | 2014 |
Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant M Salgado, M Kwon, C Gálvez, J Badiola, M Nijhuis, A Bandera, ... Annals of internal medicine 169 (10), 674-683, 2018 | 76 | 2018 |
A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation I Buño, P Nava, A Simón, M González-Rivera, JL Jiménez, P Balsalobre, ... Haematologica 90 (10), 1373-1379, 2005 | 68 | 2005 |
Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders M Kwon, G Bautista, P Balsalobre, I Sánchez-Ortega, D Serrano, ... Biology of Blood and Marrow Transplantation 20 (12), 2015-2022, 2014 | 56 | 2014 |
Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic … M Kwon, P Balsalobre, D Serrano, AP Corral, I Buño, J Anguita, J Gayoso, ... Biology of Blood and Marrow Transplantation 19 (1), 143-149, 2013 | 43 | 2013 |
Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience J Gayoso, P Balsalobre, MJ Pascual, C Castilla-Llorente, L López-Corral, ... Bone Marrow Transplantation 51 (10), 1307-1312, 2016 | 37 | 2016 |
Donor cell–derived hematologic neoplasms after hematopoietic stem cell transplantation: a systematic review J Suárez-González, C Martínez-Laperche, M Kwon, P Balsalobre, ... Biology of Blood and Marrow Transplantation 24 (7), 1505-1513, 2018 | 36 | 2018 |
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms C Martínez-Laperche, E Buces, MC Aguilera-Morillo, A Picornell, ... Blood advances 2 (14), 1719-1737, 2018 | 35 | 2018 |
Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression … A Guillaumet-Adkins, J Richter, MD Odero, J Sandoval, X Agirre, A Catala, ... Journal of Hematology & Oncology 7, 1-11, 2014 | 35 | 2014 |
In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins M Martinez-Moreno, M Leiva, N Aguilera-Montilla, S Sevilla-Movilla, ... Leukemia 30 (4), 861-872, 2016 | 34 | 2016 |
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation M Kwon, R Bailén, MJ Pascual-Cascón, AI Gallardo-Morillo, ... Blood advances 3 (21), 3351-3359, 2019 | 31 | 2019 |